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Abstract
Background: Transposable elements (TEs) are enriched in cytosine methylation, preventing their mobility within
the genome. We previously identified a genome-wide repertoire of candidate intracisternal A particle (IAP) TEs in
mice that exhibit inter-individual variability in this methylation (VM-IAPs) with implications for genome function.
Results: Here we validate these metastable epialleles and discover a novel class that exhibit tissue specificity (tsVM-
IAPs) in addition to those with uniform methylation in all tissues (constitutive- or cVM-IAPs); both types have the
potential to regulate genes in cis. Screening for variable methylation at other TEs shows that this phenomenon is
largely limited to IAPs, which are amongst the youngest and most active endogenous retroviruses. We identify
sequences enriched within cVM-IAPs, but determine that these are not sufficient to confer epigenetic variability.
CTCF is enriched at VM-IAPs with binding inversely correlated with DNA methylation. We uncover dynamic physical
interactions between cVM-IAPs with low methylation ranges and other genomic loci, suggesting that VM-IAPs have
the potential for long-range regulation.
Conclusion: Our findings indicate that a recently evolved interplay between genetic sequence, CTCF binding, and
DNA methylation at young TEs can result in inter-individual variability in transcriptional outcomes with implications
for phenotypic variation.
Keywords: Retrotransposon, Endogenous retrovirus, Intracisternal A particle, DNA methylation, Metastable epiallele,
CTCF, Chromatin conformation
Background
Transposable elements (TEs) are DNA sequences that ac-
count for about 40% of the mouse genome [1]. The vast ma-
jority (96%) of TEs are retrotransposons, which mobilise via
an RNA intermediate prior to re-integration into the genome
[1, 2]. There are three classes of retrotransposons in mam-
mals: long-interspersed nuclear elements (LINEs), short-
interspersed nuclear elements (SINEs), and long-terminal re-
peat elements (LTRs; which include endogenous retroviruses
(ERVs)). Whilst ERVs mostly exist as solo LTRs, and the ma-
jority of full-length elements have lost coding potential due
to an accumulation of mutations, some mouse ERVs retain
the ability to retrotranspose and account for up to 12% of all
germline mutations [3]. Due to the risk of insertional muta-
tion and the potential activity of internal regulatory se-
quences, retrotransposons are commonly targeted for
silencing by ncRNAs, repressive histone modifications, and
DNA methylation [4].
Of all the types of ERVs in the mouse genome, intra-
cisternal A-particle elements (IAPs) are amongst the
most active [5, 6] and evolutionarily young [2, 3, 7, 8].
Unlike 90% of the genome, IAPs have been reported to
resist the epigenetic reprogramming that occurs during
early embryonic development and remain methylated [9,
10]. It is therefore rare for IAPs to be partially or com-
pletely unmethylated. Agouti viable yellow (Avy) and
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Axin Fused (AxinFu) represent two-well studied exam-
ples of IAPs that are not fully methylated. These alleles
were first identified due to observable differences be-
tween littermates in coat colour and tail morphology, re-
spectively [11, 12] and were termed ‘metastable
epialleles’ [13–15]. It was determined that these pheno-
typic differences result from an IAP insertion and that
the methylation level of the element is inversely corre-
lated with the expression of the affected gene [16, 17].
These two IAP insertions have inter-individual variation
in DNA methylation that gives rise to individual mice
exhibiting coat colours ranging from yellow to pseudoa-
gouti (Avy), and tail morphology ranging from highly
kinked to straight (AxinFu). Furthermore, both models
transmit a memory of the parental methylation state to
the offspring, providing a paradigm for transgenerational
epigenetic inheritance [14, 16].
Previously, our group performed a systematic genome-
wide screen in C57BL/6 J mice to identify other variably
methylated IAPs (VM-IAPs) [18]. Unlike what was ob-
served at the Avy and AxinFu loci, the majority of VM-
IAPs identified in that screen did not have any detect-
able effect on the expression of adjacent genes. In off-
spring, VM-IAPs do not possess a memory of the
parental methylation state; instead, the DNA methyla-
tion at VM-IAPs is predictably reprogrammed following
fertilization and re-established stochastically in the next
generation [13]. The functional implications of DNA
methylation at these elements and the mechanisms be-
hind the establishment of variable methylation are not
fully understood.
In this study, we validate candidate VM-IAPs that show
consistent levels of methylation between tested tissues,
which we term constitutive variably methylated IAPs
(cVM-IAPs). In addition, we identify and characterise IAP
elements that only have variable methylation in some, but
not all, tested tissues and term these tissue-specific vari-
ably methylated IAPs (tsVM-IAPs). We find that cVM-
IAPs are enriched for specific sequences that may play a
role in the acquisition of variable methylation and test
whether they are sufficient to confer variable methylation.
We show an inverse correlation between binding levels of
the multifunctional transcription factor CTCF and DNA
methylation at cVM-IAPs, and identify distinct patterns of
chromatin interactions at several of these loci with levels
of DNA methylation at these loci correlating with levels of
H3K9me3. We expand our screen beyond IAP elements
and find that variable methylation is uncommon in other
types of retrotransposons. Overall, our findings suggest
that variable methylation at IAP elements occurs via com-
plex interactions between IAP sequence, CTCF binding,
histone modifications and DNA methylation machinery,
and may represent a transient evolutionary state with the
potential to cause inter-individual variability in transcrip-
tion and phenotype.
Results
Individual VM-IAPs possess constitutive or tissue-specific
methylation variability
Our previous screen for VM-IAPs was performed using
whole genome bisulphite sequencing (WGBS) datasets
from B and T cells of C57BL/6 J mice generated as part
of the BLUEPRINT consortium [18]). This resulted in
the identification of 104 candidate VM-IAP elements.
The IAP annotations used in the screen were created by
RepeatMasker, a program that identifies repetitive por-
tions of the genome (including TEs). Upon closer in-
spection we noted that many of the annotated elements
were ‘fragmented’, i.e. neither solo LTRs nor fully-
structured IAPs with tandem LTRs. Fragmented ele-
ments may arise naturally in the genome, through later
insertions of other elements, accumulation of polymor-
phisms over evolutionary time, or through interchromo-
somal recombination. RepeatMasker often separates the
components of an intact IAP into several distinct anno-
tations, resulting in an inflated proportion of fragmented
elements in the mouse genome and an inaccurate under-
standing of IAP boundaries. We therefore developed a
method to piece together elements that were artificially
fragmented in the annotation. Applying this method to
the existing annotation decreased the total count of IAP
elements in the mouse genome from 13,065 to 10,678,
and reduced the proportion of fragmented elements
from 36 to 19% (https://github.com/knowah/vm-
retrotransposons/blob/master/data/repeat_annotations/
mm10.IAP.mended.tsv).
This improved IAP annotation, along with an updated
WGBS screen algorithm (Methods), identified twelve
new candidate VM-IAPs, bringing the total to 116. We
were able to assay 103 of these IAPs (Supplemental
Table S1) using bisulphite pyrosequencing in ear – a dis-
tinct tissue from the cell types used in the screen. Of the
tested candidates, 51 elements showed variable methyla-
tion in ear, passing a threshold of ≥10% inter-individual
methylation variation. We termed these ‘constitutive
VM-IAPs’ (cVM-IAPs) (Fig. 1a, left panel and Supple-
mental Data).
We next assessed whether the 52 candidates that did
not validate in ear samples represent IAPs which are vari-
ably methylated in other tissues. Using the same tissues as
in the WGBS VM-IAP screen, we sorted B and T cells
from C57BL/6 J mice (detailed in [18]), and performed
bisulphite pyrosequencing for each candidate using these
samples. Half (26) of the candidates that did not validate
in ear were variably methylated in B cells; we termed these
‘tissue-specific VM-IAPs’ (tsVM-IAPs) (Fig. 1a, middle
panel and Supplemental Data). The candidates not
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variably methylated in ear or B cells were also not variably
methylated in T cells; these IAPs were termed ‘false posi-
tives’, representing 25% (26 out of 103) of the tested loci
and 22% of all identified candidates (Fig. 1a, right panel
and Supplemental Data).
To determine whether tsVM-IAPs possess consistent
intra-individual methylation variation, we assayed mul-
tiple tissues, including brain, liver, kidney, and testes.
These represent a diverse set of tissues derived from all
three embryonic germ layers. Ten tsVM-IAPs are vari-
ably methylated in multiple tissues (Fig. 1b, upper panel
and Supplemental Fig. S1A). These ten tsVM-IAPs dis-
play inter-tissue methylation consistency – i.e., an indi-
vidual which has low methylation in one tissue tends to
be lowly methylated in the other variable tissues (Sup-
plemental Fig. S1B). In contrast, the majority of tsVM-
IAPs (16 out of 26) are variably methylated in B cells but
not in the other tested tissues (Fig. 1b, lower panel and
Supplemental Fig. S1C). Compared to cVM-IAPs, the
tsVM-IAPs have less consistent IAP structure (Fig. 1c)
and lower methylation variability on average (Supple-
mental Fig. S1D). The multi-tissue assays used to iden-
tify the tsVM-IAPs also confirmed the lack of
methylation variability in five false positive IAPs (Sup-
plemental Fig. S1E). We cannot rule out the presence of
additional tsVM-IAPs occurring in cell types that we
have not assayed.
A role for tsVM-IAPs in transcriptional regulation
We previously reported examples of cVM-IAP–initi-
ated transcripts which overlap with annotated genes
and for some of these, the expression level correlated
inversely with the methylation level of the cVM-IAP
[18]. Around 10% of cVM-IAPs show this effect (Sup-
plemental Table 1). However, in all cases this correl-
ation was tissue-specific. We therefore probed our set
of tsVM-IAPs to characterise their effect on transcrip-
tion of nearby genes. As no tsVM-IAP was located in
the vicinity of the transcriptional start site of a gene,
we focussed on four tsVM-IAPs located within
introns of genes. We investigated whether expression
of the surrounding gene correlates with the methyla-
tion level of the tsVM-IAP; both expression and
methylation were assayed in the tissues in which the
tsVM-IAP is variably methylated (Supplemental Fig.
S1A). Using three primer sets targeted to different
exons, we found a statistically significant inverse cor-
relation between Acss2 gene expression and IAP-Acss2
methylation level in B cells (Fig. 1d), but not in brain
or kidney where the IAP was also variably methylated.
Because expression levels of exons on either side of
IAP-Acss2 were inversely correlated with the methyla-
tion level of the element, it is unlikely that this
tsVM-IAP is acting as an alternative promoter. There
was no transcriptional effect in the other three tsVM-
IAPs investigated (Supplemental Fig. S2).
Repeat-associated variable methylation is mainly a
feature of IAPs
To determine whether other families of retrotransposons
exhibit the properties of VM-IAPs, we carried out a
genome-wide screen for variably methylated LINEs,
SINEs, ERVs and non-ERV LTRs in the same WGBS data-
sets used for the IAP screen. The methylation ranges for
candidate variably methylated LINEs, SINEs, ERVs, and
non-ERV LTRs were lower compared to IAPs (LINEs,
SINEs, non-ERV LTRs, Fig. 2a; IAPs, Supplemental Fig.
S3A; ERVs, Supplemental Fig. S3B). We experimentally
validated a total of 34 elements representing the top can-
didates in each repeat family and found two new variably
methylated ERVs (VM-ERVs) in addition to 13 previously
validated [18] (Supplemental Fig. S3C). We also checked
whether the ERVs which did not pass the validation
threshold in ear samples were variably methylated in B
cells, as this was the hallmark of tissue-specific variability
in IAPs. None of the tested ERVs were variably methyl-
ated in B cells, suggesting that tissue-specific variable
methylation occurs exclusively at IAP elements (Supple-
mental Fig. S3D).
(See figure on previous page.)
Fig. 1 Genome-wide screens and site-specific validation of candidate variably methylated IAP elements (VM-IAPs) identify 51 loci with constitutive
variable methylation and 26 loci with tissue-specific variability. a Bisulphite pyrosequencing of 103 candidate VM-IAPs in ear tissue and B cells led
to classification of constitutive VM-IAPs (cVM-IAPs), tissue-specific VM-IAPs (tsVM-IAPs), or false positives – three representative examples are
shown for each. The threshold for validation as a VM-IAP is a 10% methylation range amongst individuals. IAP elements with ≥10 and < 10%
range in methylation are coloured red and black, respectively. Each point represents an individual and is the average methylation of four distal
CpGs in the LTR. n = 8 for ear samples and 7 for B cell samples. b IAP-Cyp4a12a (top) is a representative example of tsVM-IAPs with variable
methylation in multiple tissues. IAP-Mapk4 (bottom) is a representative example of tsVM-IAPs whose variable methylation is restricted to B cells. c
IAP elements of the LTR1_Mm–Ez-int (fully-structured) and the LTR2_Mm (solo LTR) types are over-represented in cVM-IAPs. The frequencies of
cVM-IAP and tsVM-IAP structures are compared with the relative frequency of genome-wide IAP structures. In the IAP type labels, fully-structured
IAPs with flanking LTRs are indicated with “–”, and incomplete IAPs missing one or both flanking LTRs are indicated with “||”. Only IAP types with
at least one cVM-IAP or tsVM-IAP are shown. d In B cells, expression of Acss2 is inversely correlated with the methylation level of the nearby tsVM-
IAP, IAP-Acss2 (two-tailed Pearson). Expression was quantified by qPCR, normalised to housekeeping genes, Pgk1 and Gapdh, and analysed across
multiple exon-exon junctions: 1–2, 3–7 and 4–7
Elmer et al. Mobile DNA            (2021) 12:6 Page 4 of 16
Aside from VM-ERVs, LINE-Gm44851 was the only
variably methylated retrotransposon that passed the val-
idation threshold of ≥10% methylation range (Fig. 2b
and Supplemental Fig. S3E). Two SINEs located on the
X chromosome with high methylation ranges in the
WGBS dataset were found to be bistable epialleles – loci
which have two methylation states within a population –
with the two methylation states segregating by sex; these
elements were excluded from further analysis (Supple-
mental Fig. S3F). In total we have identified 77 VM-IAPs
(51 constitutive and 26 tissue-specific), 15 VM-ERVs
and one VM-LINE. We compared the validated methyla-
tion ranges of individual TEs across the different repeat
families and found that VM-IAPs are more variable than
the other variably methylated TEs (Fig. 2c). These find-
ings indicate that variable methylation most commonly
occurs at IAPs and is not a universal property of TEs.
Sequence specificity of variable methylation at cVM-IAPs
IAPs can be classified into different types based on the
sequence of the LTRs (15 types) and internal portions
(10 types) [19]. The previously reported VM-IAPs were
shown to be enriched in the LTR2_Mm, LTR1_Mm, and
EY4_LTR types of IAP LTRs ([18]; ‘IAP’ prefixes omitted
for brevity). With the methylation ranges of all candidate
IAPs confirmed by pyrosequencing and the improved
annotation of IAP elements, we were able to reassess
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Fig. 2 Variable methylation in TEs is unique to evolutionarily young ERV insertions. a Methylation ranges at the edges of LINEs, SINEs and non-ERV
LTRs (denoted LTR*) in B and T cell samples from the WGBS dataset. Each point represents an individual element. Coloured points represent the top
candidates in each family, which were selected for bisulphite pyrosequencing validation. b Bisulphite pyrosequencing validation in ear tissue of the
top candidates from the WGBS screen in each repeat family. Elements with ≥10 and < 10% range in methylation between individuals are coloured in
red and black, respectively. Each point represents an individual and is the average methylation of 2–4 distal CpGs in the element; n≥ 8 for all elements
shown. c Methylation ranges of validated elements grouped by repeat family suggests that variable methylation is uncommon in LINEs, SINEs and
non-ERV LTRs, while validated IAP elements have the highest range. Each point represents an individual element. Elements with ≥10 and < 10% range
in methylation between individuals are denoted by filled and blank circles, respectively. The thin black dotted line shows the 10% threshold. The thick
black dashed lines represent the average methylation range per repeat family. Methylation was assayed in B cells for tsVM-IAPs and in ear tissue for all
other types of elements
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non–solo LTR elements into the analysis. Genome-wide,
the most common types of IAPs are, in order, LTR1a_
Mm – Ez-int and LTR1_Mm – Ez-int (both fully-
structured IAPs), followed by EY2_LTR and LTR2a2_
Mm (both solo LTR IAPs). The black bars in Fig. 1c
show the frequency of each type of IAP relative to the
most common type in the genome, LTR1a_Mm – Ez-
int. The majority (74%) of cVM-IAPs are made up of
just two types of IAPs, LTR2_Mm and LTR1_Mm – Ez-
int (Fig. 1c, green bars), despite these being only the sec-
ond and fifth most common types of IAP genome-wide.
The majority of solo LTR VM-IAPs are of the LTR2_
Mm type and the majority of full-length VM-IAPs are of
the LTR1_Mm – Ez-int type. In contrast to cVM-IAPs,
we did not find that tsVM-IAPs are enriched in any one
type of element (Fig. 1c, orange bars). These differences
– in particular, the underlying sequence difference be-
tween the IAP types – may underpin divergent mecha-
nisms responsible for variable methylation at these
elements.
It is known that CpG density is generally positively
correlated with DNA methylation, but at high CpG
densities there is an inverse correlation with DNA
methylation [20, 21]. Previously, we found that IAPs
have higher CpG density than other ERV retrotranspo-
sons in the mouse genome [18]. When comparing CpG
density between different types of LTRs, we found that
the IAP types for which cVM-IAPs are enriched, namely
LTR1_Mm – Ez-int and LTR2_Mm, have higher CpG
density than other IAP type LTRs (Supplemental Fig.
S4A). Furthermore, cVM-IAPs of the LTR2_Mm type
have significantly higher CpG density than non-variable
LTR2_Mm elements. On the other hand, cVM-IAPs of
the LTR1_Mm – Ez-int type have slightly lower CpG
density in their LTRs than non-variable LTR1_Mm –
Ez-int elements. Given these contrasts, if CpG density is
involved in establishing variable methylation states, the
mechanism by which that occurs is dependent on IAP
type. Similar to IAPs, VM-ERVs have higher CpG dens-
ity compared to ERV elements in general, but they have
lower CpG density than both cVM-IAPs and tsVM-IAPs
(Supplemental Fig. S4B).
Since IAP type and CpG density are both potential
sequence-based determinants of methylation variability
at cVM-IAPs, we sought to ascertain whether specific
sequences within the IAP LTRs may be conferring the
variable methylation. We performed a k-mer analysis to
identify enriched sequences amongst the LTRs of cVM-
IAPs (Supplemental Table S2). We identified 14 se-
quences which are each present in multiple cVM-IAP
LTRs and which are present in no more than 2% of all
IAP LTRs in the genome. A total of 37 out of the 51
cVM-IAPs contained at least one of these sequences, as
well as 6 out of the 26 tsVM-IAPs. Each sequence is
mostly present in only one type of LTR, either LTR2_
Mm or LTR1_Mm. We experimentally assessed DNA
methylation at 18 IAP elements containing multiple se-
quences enriched in cVM-IAPs and found that they
were all hypermethylated with little inter-individual vari-
ability (Supplemental Fig. S5). This proves that sequence
is not the sole determinant of variable methylation.
However, the existence of sequences enriched amongst
cVM-IAPs suggests that variable methylation may be
driven, at least in part, by underlying genetic features.
CTCF and its motif are enriched at VM-IAPs
Using CTCF ChIP-seq data from ENCODE, we previ-
ously reported that VM-IAPs appear closer to CTCF
binding sites compared to non-variable IAPs [18]. To ex-
pand and refine our previous findings, we generated
CTCF ChIP-seq datasets from livers of eight individuals
(Additional File 1). Although the presence of a binding
site can be easily determined for a given element, it is
difficult to discern whether CTCF binds within the IAP
itself or its flanking regions. This is because the ChIP-
seq fragments from IAPs often do not contain unique
sequence, meaning they cannot be mapped confidently
to a specific IAP element. To address this, we mapped
the CTCF ChIP-seq datasets to consensus sequences of
all named IAP LTR types and found that CTCF is
enriched in four LTR types (Supplemental Fig. S6A), in-
cluding those that are specifically enriched among cVM-
IAPs (LTR2_Mm and LTR1_Mm) (Fig. 1c).
To generate a robust CTCF binding motif that corre-
lates with strong CTCF binding, we identified a 14 nu-
cleotide sequence matrix (i.e., motif) derived from the
top 10% of ChIP-seq peaks across the pooled eight data-
sets (Fig. 3a). Binding sites matching this motif are
present in around 10% of IAP LTRs at the 5′ end of the
U3 region (Fig. 3b-c). When analysing CTCF enrichment
at specific IAP elements, we found that most IAPs are
not bound by CTCF, including many of those which
contain the motif (Fig. 3c). In contrast, almost all the
cVM-IAPs are enriched for CTCF binding and only five
elements do not have the motif (Fig. 3d). Although
tsVM-IAPs are not as ubiquitously bound by CTCF as
cVM-IAPs, those that are enriched for CTCF binding
tend to be variably methylated in liver, the tissue used to
generate the ChIP-seq datasets (Fig. 3e). This validates
and refines our previously reported finding that CTCF is
specifically enriched at VM-IAPs compared to other
IAPs in the genome and suggests that there may also be
a relationship between CTCF and tsVM-IAPs.
To ask whether the CTCF enrichment at cVM-IAPs is
due to the sequence of the CTCF binding site within
those elements, we generated motifs using only the bind-
ing sites within IAPs, cVM-IAPs, and tsVM-IAPs (Sup-
plemental Fig. S6B). The similarity of these motifs both
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to each other and to the more general genome-wide
motif suggests that the specific sequence of the binding
site is unlikely to be the cause of the specific CTCF en-
richment at cVM-IAPs.
CTCF binding and DNA methylation have an inverse
relationship at cVM-IAPs
There is a known inverse relationship between DNA
methylation and reduced CTCF binding at many regions
in the genome, including imprinted genes and some dif-
ferentially methylated regions [22–31]. In addition, many
CTCF binding sites in the mouse and human genomes
are located within TEs [32–35]. We used our ChIP-seq
datasets to ask if CTCF binding is variable between indi-
viduals at cVM-IAPs, and if so, whether there is a rela-
tionship between CTCF binding and DNA methylation.
We found that at six out of the seven analysed cVM-
IAPs, there is a significant inverse correlation between
DNA methylation at the cVM-IAP and CTCF binding
(Supplemental Fig. S7A).
This inverse relationship was validated by performing
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Fig. 3 CTCF binding is enriched at VM-IAPs relative to other IAPs in the mouse genome. a CTCF motif derived from the top 10% of CTCF ChIP-
seq peaks from the combined peak calls of eight individual liver samples. b IAP LTRs are divided into U3 (green), R (orange), and U5 (purple)
substructures. Colour boundaries represent the median location of the substructure boundaries; colour gradients represent the middle 50% of the
distribution of those boundaries (top plot). The CTCF motif is enriched at the 5′ end of the IAP LTRs (bottom plot), within the U3 substructure. c-e
Presence of the CTCF motif within the IAP LTR (horizontal black bars) alongside CTCF ChIP-seq enrichment in liver (heatmaps) at c fully-structured
and solo LTR IAPs (excluding VM-IAPs), d cVM-IAPs, and e tsVM-IAPs; circles represent tsVM-IAPs with methylation ranges in liver of 9–10%
(orange) and≥ 10% (red). CTCF enrichment score scale bar in (c) also applies to (d) and (e). For the solo LTR plots, the vertical black lines denote
the 5′ and 3′ ends of the solo LTR. For the fully-structured IAP plot, the vertical black lines denote the 5′ and 3′ ends of the entire IAP. Note that
the ‘fully-structured’ plots include fragmented IAPs. Heatmaps are ordered by the score in the tile preceding the 5′ edge of each IAP
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same eight individuals on which we performed the
ChIP-seq experiments (Fig. 4 and Supplemental Fig.
S7B), calculating fold enrichment relative to IAP-Ell2
and to IAP-Dst (both non-variable hypermethylated
IAPs, Supplemental Fig. S7C). We found that CTCF
binding is also variable at some non-variably methylated
IAPs (Supplemental Fig. S7D), which is consistent with
reports that CTCF binding can be methylation sensitive
at some loci and not at others [28, 36]. Our data indicate
that methylation is associated with the level of CTCF
binding at cVM-IAPs. In contrast to CTCF binding,
H3K9me3 levels correlated positively with DNA methy-
lation at these loci (Supplemental Fig. S8).
Chromatin interactions with cVM-IAPs
CTCF is important for establishing chromatin architec-
ture [37–40] and recent findings suggest that TEs bound
by CTCF can contribute to chromatin looping, which in
turn can influence gene regulation [41–43]. Therefore,
we hypothesized that inter-individual variation in CTCF
binding at cVM-IAPs could contribute to variation in
genome topology. We investigated this using circularised
chromatin conformation capture sequencing (4C-seq), a
technique used to reveal chromatin interactions between
a locus of interest and other parts of the genome. We
performed 4C-seq on five individual mice at four cVM-
IAPs (IAP-Marveld2, IAP-Tfec, IAP-Pink1, and IAP-
Mbnl1) and one non-variable IAP (IAP-Dst) (Supple-
mental Fig. S9). In a 400 kb window surrounding the ele-
ments, we found that the two cVM-IAPs that were lowly
methylated within individuals (IAP-Marveld2 and IAP-
Tfec) have more long-range and variable interactions
compared to the two cVM-IAPs that were highly meth-
ylated within individuals, which show fewer interactions
(IAP-Pink1 and IAP-Mbnl1). The control non-variable
IAP has a more uniform interaction pattern. Due to
limited sample size we were unable to confidently quan-
tify differential interactions between individuals.
Methylation variability is not confined to the LTR
boundaries of cVM-IAPs
To determine the extent to which methylation variability
exists outside of the LTR, we first assessed the DNA
methylation within 1 kb of cVM-IAPs by bisulphite py-
rosequencing. This revealed that variable methylation
between individuals extends outside the TE and into the
adjacent unique sequence (Fig. 5a and Supplemental Fig.
S10A). The relative order of methylation levels across in-
dividuals is maintained until inter-individual variability
is lost, at a position around 500-1000 bp from the end of
the LTR. Although methylation levels beyond this point
can show some variability between the individuals (Fig.
5b and c, and Supplemental Fig. S10B and C), this oc-
curs independently of the VM-IAP since the relative
order of methylation levels across individuals is no lon-
ger retained.
We next considered whether the methylation variabil-
ity at cVM-IAPs and beyond is associated with a distinct
methylation pattern near the elements. By examining the
WGBS datasets, we found that the distribution of DNA
methylation in the 5 kb flanking each element is not uni-
form amongst all 51 cVM-IAPs (Supplemental Fig.
S10B). We observed a variety of methylation patterns,
including fully hypermethylated flanks, hypomethylated
regions, intermediately-methylated regions, and tissue-
specific methylation; these patterns are not mutually ex-
clusive. We confirmed this by performing bisulphite py-
rosequencing on the flanking regions of six cVM-IAPs
representative of these patterns (Fig. 5b and c, and Sup-
plemental Fig. S10C). For example, at the regions flank-
ing IAP-Marveld2, we found hyper- and intermediate
methylation (Fig. 5b), and at the regions flanking IAP-















CTCF ChIP-qPCR fold enrichment
R2 = 0.9915
p < 0.0001









CTCF ChIP-qPCR fold enrichment
Fig. 4 DNA methylation and CTCF binding are inversely correlated at VM-IAPs. There is an inverse relationship between CTCF ChIP-qPCR fold
enrichment (relative to CTCF enrichment at IAP-Ell2) and DNA methylation (measured by bisulphite pyrosequencing) in eight liver samples at IAP-
Marveld2 and IAP-Tfpi. Each coloured point represents the average methylation of the four distal CpGs in the LTR of an individual. The colours
represent the same individuals across both plots and show that the relative order of CTCF binding is not the same in each element. P-values are
from two-tailed Pearson test
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Bex6, we found a tissue-specific methylation pattern that
differed between the B and T cells (Fig. 5c), as expected
from the WGBS data. These findings suggest that a par-
ticular flanking DNA methylation landscape is not re-
quired for variable methylation, nor do VM-IAPs
influence the flanking DNA methylation landscape in a
specific way.
Discussion
Using WGBS data combined with bisulphite pyrose-
quencing of independent samples, we classified 51 VM-
IAPs as constitutive, meaning variably methylated in all
tested tissues, and 26 as tissue-specific, of which 16 were
only variably methylated in B cells. Furthermore, fifteen
VM-ERVs were also identified. This provides a validated
resource of murine (C57BL/6 J) metastable epialleles for
further studies.
Given the hypothesis that recently active retrotranspo-
sons may have facilitated the rapid adaptive evolution
undergone by protein-coding immune genes [44–47], it
is noteworthy that tsVM-IAPs are enriched for variable
methylation in B cells, an immune cell population. We
also found an inverse correlation between the methyla-
tion level of a tsVM-IAP and gene expression; the
Fig. 5 Methylation variability is not confined to the LTRs of VM-IAPs. a Bisulphite pyrosequencing of liver samples from five individuals shows
inter-individual methylation variation within 500-1000 bp beyond the edge of six cVM-IAP LTRs. b-c WGBS data from B and T cells (light red and
blue) in the region flanking cVM-IAPs with bisulphite pyrosequencing (Pyro) validation in b five liver samples (black) at IAP-Marveld2 and c B cells
and T cells (red and blue) from four individuals at IAP-Bex6. IAP length is not to scale. For the pyrosequencing data, each dot represents a CpG.
The dashed vertical lines represent the 5′ and 3′ ends of the IAPs
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transcriptional effect was specific to B cells, despite the
presence of variable methylation in other tissue types.
DNA methylation variability between individuals is not
confined to the boundaries of cVM-IAPs, but also exists
in the immediate flanking regions. A few rare examples
of DNA methylation spreading from fully methylated
retrotransposons have been reported [48–55]. In all
tested cVM-IAPs, we found variable methylation within
500 bp of the element boundaries, and sometimes be-
yond, suggesting that any effects of variable TE methyla-
tion may extend into the adjacent sequence. This, along
with our finding that the methylation of a tsVM-IAP can
correlate with the expression of a nearby gene, indicates
that VM-IAPs have potential cis-regulatory effects. The
absence of a common pattern at these boundaries indi-
cates that VM-IAPs do not confer, or be influenced by, a
flanking genomic landscape in a specific way.
We have shown that CTCF is highly enriched at cVM-
IAPs and tsVM-IAPs compared to other IAPs in the
genome. Unlike VM-IAPs, many non-variable IAP LTRs
contain a CTCF motif yet are not bound by the protein;
this may be because the majority of IAP LTRs are hyper-
methylated and CTCF binding is sensitive to methyla-
tion. Although it is already known that TEs harbour and
spread CTCF binding sites throughout mammalian ge-
nomes through mobilisation [33, 34], it is not clear to
what extent these CTCF binding sites affect gene regula-
tory function. Some studies have indicated that the
methylation sensitivity of CTCF is not a major contribu-
tor to its function [28, 36], although this is not the case
at imprinted domains [22–24, 56]. CTCF is known
for its role in establishing genomic interactions; we
found that these interactions vary depending on the
methylation range of the element whereby lowly-
methylated cVM-IAPs appear to have more interac-
tions than highly-methylated cVM-IAPs. However,
whether the CTCF bound to cVM-IAPs contributes to in-
teractions with specific loci is yet to be determined. It has
been shown in both mouse and human that TE insertions
enriched for CTCF induce differential loop formation that
is significantly associated with effects on gene expres-
sion [42]. Our results indicate that epigenetic differ-
ences at TEs might also influence CTCF-mediated
conformational states.
Results presented here point to mechanisms for when
and how variable methylation at TEs is established. The
identification of multiple tsVM-IAPs shows that variable
methylation can occur in a tissue-specific manner, which
indicates that VM-IAPs can likely arise at different de-
velopmental time points. As originally observed at the
Avy and AxinFu loci, cVM-IAPs have inter-individual
methylation variation but consistent methylation levels
within an individual across tissues, indicating that vari-
able methylation establishment at these loci likely occurs
prior to germ layer specification [18, 57, 58]. Since the
extent of methylation variation and the absolute methy-
lation levels differ between tissues at tsVM-IAPs, the
mechanisms underlying establishment of variable methy-
lation at these loci are likely to be different from those
at cVM-IAPs, and probably occur later in development.
These findings also suggest that, rather than being resist-
ant to the early developmental erasure and re-establish-
ment of methylation as has been proposed for IAP
elements in general [9, 59], the VM-IAPs (which rep-
resent around 1% of the ~ 10,000 IAP elements) have
increased susceptibility to this developmental process
[18].
Transcription factor binding at cVM-IAPs and the
genetic sequence of cVM-IAP LTRs are likely contribu-
tors to the mechanism underlying establishment of vari-
able methylation. We rule out the possibility that
genomic methylation context is an important factor in
establishing variable methylation by showing that there
is no discernible common pattern of DNA methylation
flanking cVM-IAPs. Moreover, a correlation between
methylation and H3K9me3 was observed along with an
inverse correlation between the enrichment of transcrip-
tion factor CTCF and DNA methylation at cVM-IAPs.
During early development, CTCF may compete with
DNA methylation machinery for access to VM-IAP
LTRs. This hypothesis is consistent with research show-
ing that CTCF can influence the presence or absence of
DNA methylation during development with functional
consequences [22–25, 28, 36, 56, 60–63]. Therefore, the
molecular antagonism between CTCF and DNA methy-
lation machinery could contribute to the formation of
variable methylation levels between genetically identical
individuals. CTCF may also facilitate interactions with
genomic regions that contribute to the regulation of
VM-IAP methylation.
The updated categorisation of VM-IAPs revealed that
the majority of cVM-IAPs are solo LTR2_Mm or full
length LTR1_Mm – Ez-int elements, while tsVM-IAPs
are not enriched for any specific type of IAP. This is fur-
ther evidence that cVM-IAPs and tsVM-IAPs likely arise
via separate mechanisms. We have also identified se-
quence correlates and CpG density profiles of variable
methylation at IAPs. Subsets of cVM-IAPs are highly
enriched for specific sequences compared to other IAPs
in the genome, however these are unable to predict vari-
able methylation. At this point it is unclear exactly how
the enriched sequences contribute to establishing vari-
able methylation. A plausible explanation is that they
contain binding sites for transcription factors such as
CTCF or KRAB zinc finger proteins (KZFPs) [34, 64].
KZFPs are the largest family of transcription factors in
mammals and are known to coevolve with and regulate
TEs by recruiting heterochromatic machinery to distinct
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loci in a sequence specific manner [65–68]. KZFPs are
rapidly evolving and highly polymorphic between verte-
brates and even among different mouse strains [69].
Variable methylation could arise if there were changes in
KZFP binding sites within the VM-IAPs or the binding
domains of specific KZFPs that target VM-IAPs. Ultim-
ately, the enrichment of specific sequences at VM-IAPs
could contribute to variable methylation via novel or dis-
rupted protein interactions.
The genome-wide screens that we have conducted at
TEs in mouse reveal that variable methylation is a rare
occurrence that is mostly restricted to IAPs, which are
amongst the evolutionarily youngest ERV types [70].
Whether variable methylation is a phenomenon exclu-
sive to young TEs is an open question. Genome-wide
screens for metastable epialleles at non-repetitive regions
have been performed on the human genome, and vari-
ably methylated non-repetitive regions appear to exist
[71, 72]. The extent to which these regions are driven by
inter-individual genetic differences has not yet been fully
determined as it is difficult to eliminate the confounding
effect of human genetic variation. Due to the difference
in how TEs and non-repetitive regions are regulated by
DNA methylation [73], it is likely that the overarching
mechanisms of variable methylation establishment and
its potential function also vary between these two types
of genomic loci.
Conclusions
We have shown that VM-IAPs have the capacity to
affect gene regulation by either cis or long-range mecha-
nisms and in a tissue-specific manner. Addressing the
question of what defines a VM-IAP is made more diffi-
cult by the fact that there is no unifying characteristic
which distinguishes them from the other 99% of IAPs.
Instead, we have shown that there are correlations of
varying specificity and confidence by which subpopula-
tions of VM-IAPs differ from the main IAP population
with regards to tissue-specific methylation states, CTCF
binding, histone modifications, genomic sequence, and
CpG density. This shows that there are multiple factors
contributing to variable methylation between individuals.
The functional implications of TE epigenetic variability
and the extent to which this can influence phenotypic
outcome remain to be determined.
Methods
Improving the catalogue of IAPs
The GRCm38/mm10 RepeatMasker (henceforth RM)
annotation (Dfam v4.0.7) was downloaded from the
UCSC table browser [19, 74]. This annotation set con-
tains entries for each transposable element, which may
be categorized into one or more ‘subelements’, which
are united by an ‘element ID’. All transposable elements
that were considered IAP elements contained at least
one IAP subelement of the following types: IAPLTR1a_
Mm, IAPEY2_LTR, IAPEy-int, IAPEY3_LTR, IAPL
TR2b, IAPLTR2_Mm, IAPEz-int, IAPEY4_I-int, IAP-d-
int, IAPEY3-int, RLTR10B2, IAP1-MM_I-int, IAP1-
MM_LTR, IAPLTR2a2_Mm, IAPLTR4, IAPLTR1_Mm,
IAPEY3C_LTR, IAPLTR4_I, IAPLTR3, IAPLTR3-int,
IAPEY5_LTR, IAPEY5_I-int, IAPEY_LTR, IAPEY4_LTR,
IAPA_MM-int.
Elements in the RM annotation that overlap 500 kb
boundaries were erroneously categorized as two entries
with separate element IDs. Each element at one of these
boundaries was patched to unify the two entries under
the same element ID.
Furthermore, many of the elements are ‘fragmented’
for the following reasons: subsequent insertion of other
transposable elements; sequence divergence from the
Dfam models; general poor performance of RepeatMas-
ker at ERV elements; or the retrotransposition of an
already fragmented IAP element. An element is ‘frag-
mented’ if is neither fully-structured (containing an in-
ternal portion comprised of ERV genes flanked by
tandem LTRs) nor a solo LTR (a single LTR with no
ERV genes, formed from intra- or inter-element recom-
bination of two LTRs [75].
For each fragmented element annotated as missing a
5′ LTR, the following heuristic was used in an attempt
to ‘mend’ it, forming a fully-structured IAP: (1) merge
the element with an adjacent fragmented element miss-
ing a 3′ LTR; (2) merge the element with an adjacent
solo LTR; (3) merge the element with an adjacent fully-
structured IAP. Adjacent elements must have been
within 2000 bp of the 5′ end of annotation to form a
match. The same algorithm was used for fragmented ele-
ments missing a 3′ LTR, or vice versa. Note that some-
times an element was annotated as containing just an
internal portion, so the attempt at mending was per-
formed on both edges. Step 3 of the heuristic could re-
sult in the formation of a double or higher-order fully-
structured IAP.
Screen for variably methylated transposable elements
A screen for VM-IAPs, similar to that described in
Kazachenka et al. 2018, was performed using the im-
proved catalogue of IAPs. The 16 C57BL/6 J whole-
genome bisulphite sequencing (WGBS) datasets (8 T cell
samples, 8 B cell samples) from the BLUEPRINT Epige-
nome project [76] were mapped to the mm10 reference
using Bismark v0.20.0 with default options [77]. This
dataset contains 8 ‘standard’ WGBS and 8 oxidative
WGBS samples, which were not distinguished in the
analysis since hydroxymethylation levels are very low in
these samples. Methylation calls were obtained from the
aligned reads with a MAPQ ≥10. LTR methylation states
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in each sample were calculated at the 5′ and 3′ edge of
each IAP element by determining the average methyla-
tion level of the 8 CpGs nearest each LTR edge (only the
two outward-facing edges were considered for each
element; the internal-facing LTR edges of fully-
structured IAPs were excluded). At each LTR edge, a
sample with fewer than 20 methylation calls across the 8
CpGs, or fewer than 4 CpGs with coverage, was consid-
ered uninformative. LTR edges with fewer than 5 in-
formative samples in either cell type were then excluded
from further analysis. The methylation range at each
LTR edge surviving these filtering steps was then calcu-
lated in each cell type. Unlike in the previous screen,
inter-replicate methylation ranges were calculated with-
out excluding the highest and lowest methylation values
in each cell type, as this conservative measure was
deemed unnecessary in light of the improved IAP refer-
ence and stricter filtering on both read quality and
region-level coverage.
The screen in LINE, SINE, and non-ERV LTR ele-
ments was performed in a similar manner with some
modifications: the RepeatMasker annotation was only
fixed by combining adjacent elements of the same class
within 100 bp of each other; and only the first 8 CpGs
within 200 bp of each element edge were considered.
k-mer and CpG density analysis
All sequences of length 15 nt (k-mers with k = 15)
present in two or more of the 5′ LTRs of the cVM-IAPs
(N = 51) were identified using Jellyfish v2.3.0 [78]. En-
richment of each k-mer (N = 2363) was then calculated
relative to a background set of IAP 5′ LTRs (N = 9650).
k-mers present in at least 5 cVM-IAPs and with an en-
richment of at least 20-fold (N = 229) were then grouped
by sequence, such that all k-mers in a group overlap
with another k-mer in the group by k-1 nucleotides.
Each group was then merged into a single extended se-
quence using abyss-align from the tool ABySS v2.2.3
[79]. The extended sequences were then trimmed to the
sub-sequence maximising the enrichment in cVM-IAPs
versus background IAPs. Identified sequences are listed
in Supplemental Table S2; pyrosequencing primers are
listed in Supplemental Table S1.
CpG density was calculated for IAP LTRs by normalis-
ing the number of CpGs in the LTR by the LTR length
in base pairs.
Tissue collection, DNA/RNA extraction and bisulphite
pyrosequencing
Immediately following dissection, C57BL/6 J tissues were
snap frozen in liquid nitrogen and manually pulverised.
30μg of tissue (brain, liver, kidney, testes, B and T cells)
was used for simultaneous purification of genomic DNA
and total RNA with the AllPrep DNA/RNA Mini Kit -
Quick-Start Protocol (QIAGEN, cat. no. 80204). Ear
notch samples were lysed (Lysis Buffer: 10 mM EDTA,
150 mM NaCl, 10 mM Tris-HCl pH 8, 0.1% SDS) and
DNA was purified using a standard phenol chloroform
extraction protocol. 0.5-1 μg of DNA per sample was
bisulphite converted using the two-step protocol of the
Sigma Imprint® DNA Modification Kit according to the
manufacturer’s instructions. Following PCR amplifica-
tion, CpG site-specific methylation was quantified using
the PyroMark™ Q96 MD pyrosequencer (Biotage) as pre-
viously described [18]. Primers are listed in Supplemen-
tal Table S1 (for IAPs, ERVs, LINEs, SINEs, non-ERV
and spreading).
B and T cell sorts
Splenic tissue was ground through a 70 μM cell strainer
to obtain a single cell suspension in PBS with 2% heat-
inactivated fetal calf serum (FCS). Red blood cell lysis
was performed on ice using cold ammonium chloride
(Stem Cell Technologies, cat. No 07800). Cells were sub-
sequently stained as described in the panel (Table 1) for
30 min at 4 °C. Cells were washed twice with 2% FCS in
2 ml PBS. 7-aminoactinomycin D (7-AAD) (1:100; Biole-
gend, 420,404) was added as a viability stain. Using an
Influx Cell Sorter (BD Biosciences), cells were sequen-
tially gated based on cell size, presence of singlets, and
live cells to sort CD3+, CD4+, CD25-, CD44lo, CD62L+
T cells and CD19+ CD43- B cells. The sorted popula-
tions include naïve CD4+ T cells and T1, T2, marginal
zone and follicular B cells. Gates were confirmed using
‘fluorescence minus one’ controls for CD44 and CD43
markers.
RT-qPCR
RNA was treated with RNase-free DNase I (Thermo-
Scientific, EN0521) prior to cDNA synthesis using
RevertAid H Minus First Strand cDNA Synthesis Kit
with oligo dT and random hexamer primers (Thermo-
Scientific). qPCR primers were designed using Primer-
BLAST and are listed in Supplemental Table S3. qPCR
was performed with Brilliant II SYBR® Green QPCR
Master Mix (Agilent Technologies) in a LightCycler® 480
Table 1 Fluorophores for B and T cell panel
Antigen Fluorochrome Clone Company Catalogue Number
CD19 BV711 6D5 Biolegend 115,555
CD43 APC S11 Biolegend 143,207
CD3 FITC 17A2 Biolegend 100,203
CD4 APC/Cy7 RM4–5 Biolegend 100,525
CD25 BV421 PC61 Biolegend 102,033
CD44 PE/Cy7 IM7 Biolegend 103,029
CD62L PE MEL-14 Biolegend 104,407
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Instrument II (Roche). Relative gene expression was cal-
culated using the standard curve method and cDNA in-
put was normalised using housekeeping genes Pgk1 and
Gapdh. The significance of correlations between gene
expression and VM-IAP methylation levels was assessed
by computing Pearson correlation coefficients followed
by two-tailed p values in GraphPad Prism.
Chromatin immunoprecipitation (ChIP) - qPCR and
sequencing
Chromatin immunoprecipitation (ChIP) was performed
as previously described with some modifications [65].
100 mg of powdered frozen mouse liver was crosslinked
in 1% formaldehyde for 10 min and subsequently
quenched with Tris pH 8.0 (250 mM final) for 10 min.
The quenched cells were washed twice with ice-cold
PBS supplemented with a protease inhibitor cocktail
(EDTA-free cOmplete™, Sigma Aldrich), flash frozen in
liquid nitrogen, and stored at − 80 °C. Crosslinked cells
were thawed on ice and then lysed sequentially on ice
and for 10 min at each step in each of the following
buffers: LB1 (50 mM HEPES- KOH pH 7.4, 140 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, 10% Glycerol, 0.5%
NP-40, 0.25% Triton-X-100 and EDTA-free cOmplete™),
LB2 (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA and EDTA-free cOmplete™), and
SDS shearing lysis buffer (10 mM Tris-HCl pH 8, 1 mM
EDTA, 0.15% SDS and EDTA-free cOmplete™). The ly-
sates were sonicated (Bioruptor) at 4 °C to generate
DNA fragments of 100–500 bp (3 repetitions of 5 sonic-
ation cycles of 30 s on and 30 s off for the CTCF ChIP; 1
repetition of 8 cycles of 30 s on and 30 s off for the
H3K9me3 ChIP) and the sonicated lysates were subse-
quently clarified by centrifugation (15,000 rpm for 15
min at 4 C). The sonicated lysate was divided into 1.5-
mL Eppendorf tubes based on the number of ChIPs per-
formed and topped up to 1 mL with Lysis Buffer
500NaCl (20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1
mM EDTA, 0.5 mM EGTA, 1% Triton-X-100, 0.1% So-
dium deoxycholate, 0.1% SDS and EDTA-free
cOmplete™). This mixture was incubated overnight at
4 °C with beads (Protein A Dynabeads, Invitrogen, for
CTCF ChIP; Protein G Dynabeads, Invitrogen, for
H3K9me3 ChIP) that had been pre-blocked with 0.5%
BSA and mixed with polyclonal CTCF antibody
(C15410210–50, Diagenode) or polyclonal H3K9me3
antibody (AB_2532132, Active Motif). To remove non-
specifically bound proteins from the CTCF ChIP, beads
were washed five times with RIPA Buffer (50 mM HEPE
S-KOH, pH 7.4, 500 mM LiCl, 1 mM EDTA, 1% NP-40
and 0.7% Sodium deoxycholate) and once with TE Buffer
(50 mM Tris-HCl, pH 8.0, 10 mM EDTA) at 4 °C. To re-
move non-specifically bound proteins from the
H3K9me3 ChIP, beads were washed twice with low salt
buffer (10 mM Tris-HCl pH 8.0, 150mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.15% SDS, 1 mM PMSF)
followed by single successive washes with high salt buf-
fer (10 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 0.15% SDS, 1 mM PMSF), LiCl
buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.5 mM
EGTA, 250mM LiCl, 1% NP40, 1% Na- deoxycholate, 1
mM PMSF), and 10 mM Tris pH 8.0 at 4 °C. The DNA-
protein complex was eluted from the beads in Elution
Buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA and 1%
SDS) for 20 min at 65 °C, and reverse-crosslinked over-
night at 65 °C. The eluted samples were then treated
with RNase A (Wako) and Proteinase K (Roche), and
purified using a PCR purification kit (NEB).
qPCR was performed with Brilliant II SYBR® Green
qPCR Master Mix (Agilent Technologies) in a LightCy-
cler® 480 Instrument II (Roche). The ChIP-qPCR fold
enrichments are calculated by 2ΔCt, where ΔCt is the dif-
ference in qPCR Ct value between the tested IAP and a
control IAP (either IAP-Dst, IAP-Ell2, or IAP-Asxl3).
qPCR primers were designed using Primer-BLAST and
are listed in Supplemental Table S3.
ChIP-seq libraries were prepared using KAPA
Adapters, KAPA HyperPrep Kit (KAPA Biosystems), and
AMPure XP Beads (Beckman Coulter) and quality
checked using Qubit, Bioanalyzer, and Tapestation. The
libraries were sequenced as 150 bp paired-end reads on
the Illumina HiSeq4000. The resulting ChIP-seq data
was trimmed by Trim Galore and aligned using bwa
0.7.15. For heatmaps, bamCompare from deeptools 3.3.1
was used to generate CTCF binding scores in 50-bp tiles
across the genome, using the combined reads of all eight
individuals. Each IAP element is split into five equal-
sized tiles. The score is the log2 ratio of ChIP reads to
input reads; Integrative Genomics Viewer (IGV) was
used to visualise a bedGraph file of the log2 ratios. Using
only reads with MAPQ≥10, ChIP peaks and summits
were called by MACS2 2.1.0 as described in [80] and
were visualized using custom R scripts (see Data Ac-
cess). Genomic context of CTCF peaks in Additional File
1 was analysed using the ChIPQC package from R/Bio-
conductor [81]. The MACS2 summits from all 8 CTCF
ChIP-seq samples were combined, and the sequence of a
50 bp window centred on each summit (N = 97,746 sum-
mits) was used as input to MEME 5.0.4, using the strat-
egy of motif finding from [33]. The FIMO tool from
MEME was then used to identify genome-wide locations
of the top motif.
4C-seq
4C-seq was performed as previously described with
some modifications [82]. Tissues were fixed as outlined
in the ChIP protocol above. DpnII (New England Bio-
labs) was used as the primary restriction enzyme and
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NlaIII (New England Biolabs) as the secondary restric-
tion enzyme. Prior to library preparation, samples were
purified by the Monarch PCR & DNA Cleanup Kit (New
England Biolabs). For the library preparation, 16 individ-
ual PCR reactions were performed for each sample per
viewpoint with reverse primers containing indexes (see
Supplemental Table S4). The 16 PCRs were combined
and purified using 0.8x Agencourt AMPure XP beads
(Beckman Coulter). Five libraries for each of the five
tested viewpoints were multiplexed, quality checked
using Qubit and Bioanalyzer, and sequenced as 150 bp
paired-end reads on the Illumina HiSeq4000. The se-
quencing data for each viewpoint were processed using
the smoothCounts method from the R Bioconductor
package FourCSeq [83]. Read counts for each restriction
fragment were then normalised and log transformed.
The trend line and its 95% confidence interval were gen-
erated by the loess.sd method from the R package msir
using span = 0.01 [84]. ChromHMM data is from mouse
liver, and was downloaded from a public GitHub reposi-
tory https://github.com/gireeshkbogu/chromatin_states_
chromHMM_mm9/blob/master/liver_cStates_HMM.zip
and lifted over to mm10 [85]. Gene tracks are from the
R Bioconductor package EnsDb.Mmusculus.v79.
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